


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+5.06%
+0.44%
-0.84%
+2.50%
+4.91%
PROF
Profound Medical Cor
$8.44
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
Risk Analysis

Trading above its fair value
PROF Price Performance
$7.69 (+9.75%)
$5.76 (+46.53%)
$4.58 (+84.28%)
$6.45 (+30.85%)
PROF has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Low volume

PROF overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Earnings decline YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading above its fair value
![]()
PROF Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
PROF Street Sentiment is unimpressive and have negative views on the near-term outlook
SYK
367.54
+0.09%
MMSI
86.38
-7.30%
IINN
0.93
-1.59%
BSX
97.64
-0.76%
What is PROF current stock price?
What are PROF stock strengths?
What is PROF Risk Level?
What is PROF market cap and volume?
What is PROF current Stock IQ?
Should I buy PROF stock right now?
Is PROF a Strong Buy right now?
What does a 'Strong Buy' rating mean for PROF?
What does a 'Strong Sell' rating mean for PROF?
What factors influence PROF's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+5.06%
+0.44%
-0.84%
+2.50%
+4.91%
PROF
Profound Medical Cor
Current Price
$8.44
PROF Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
Risk Analysis

Trading above its fair value
Linked to PROF
SYK
367.54
+0.09%
MMSI
86.38
-7.30%
IINN
0.93
-1.59%
BSX
97.64
-0.76%
Recently Viewed
PROF
Profound Medical Cor
8.44
-0.47%
IIPR
Innovative Industrial Pro
50.60
+1.48%
LFMD
LifeMD
3.86
-3.50%
PG
Procter Gamble
141.87
+0.24%
TU
Telus Corporation
13.36
+0.07%

PROF Price Performance
$7.69 (+9.75%)
$5.76 (+46.53%)
$4.58 (+84.28%)
$6.45 (+30.85%)
PROF Analysts Opinion
PROF Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Earnings decline YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading above its fair value
![]()
PROF Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
PROF Street Sentiment is unimpressive and have negative views on the near-term outlook
PROF has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Low volume

PROF Latest Analysis
Bravos Annual Letter to Shareholders. ) (".Bravo". or the ".Company".) today issued its Annual Letter to Shareholders as per below (the ".Letter".). Dear fellow ShareholdersIt is with immense gratitude and a profound sense of accomplishment that I address you at the close of 2025 a year that will undoubtedly be marked as a watershed moment for Bravo Mining Corp.This past year represents a clear inflection point in the Company'.s evolution one defined by disciplined execut
Wed Dec 31, 2025
Profound Medical Corp. Announces Closing of Private Placement.
Tue Dec 30, 2025
Global Times: Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era receives high recognition from intl community: 2025 Global Survey on Impression and Understanding of China. BEIJING Dec. 29 2025 /PRNewswire/ -- In 2025 the world is undergoing accelerated transformation amid rising turbulence and uncertainty. The interconnectedness between Chinas development and the global landscape continues to grow with China exerting increasingly profound and positive...
Mon Dec 29, 2025
Profound Medical increases private placement to $6.45M.
Wed Dec 24, 2025
Profound Medical Corp. Announces Upsize of Private Placement.
Wed Dec 24, 2025
Profound Medical Corp. Closes $36 Million Registered Direct Offering. Expects to Complete Subsequent Private Placement On or Before December 30th. Financing included participation by healthcare-dedicated investors alongside existing shareholders
Tue Dec 23, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
PROF Stock trends
PROF Stock performance
PROF Stock analysis
PROF investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.